Track record of delivering clinical assets through collaborative partnerships
Using our proprietary platform we discover therapeutic antibodies that meet the highest standards of quality and developability. Isogenica has the in-house capability and expertise to efficiently undertake and manage all discovery & development activities from programme start to development.
Isogenica’s partnerships with global biopharmaceutical companies have resulted in a deep pipeline including two clinical assets and eight partnered pre-clinical and discovery programs.
Our experienced team learned their craft at Ablynx, Bicycle Therapeutics, Roche and other leading biopharma.